NCT00972556

Brief Summary

This prospective clinical randomized controlled trial is established to compare the clinical, radiographic, and histological treatment outcomes between MTA and FC in pulpotomized human primary molars at 6, 12, 18, 24 month post-treatment and to test the hypothesis that Gray Mineral Trioxide Aggregate (GMTA) is a viable alternative to Diluted (20%) Formocresol (DFC) in pulpotomies treatment of human primary molars.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

September 3, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 7, 2009

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

August 23, 2012

Status Verified

August 1, 2012

Enrollment Period

3.8 years

First QC Date

September 3, 2009

Last Update Submit

August 22, 2012

Conditions

Keywords

Mineral Trioxide AggregateFormocresolpulpotomyprimary molartreatment outcome

Outcome Measures

Primary Outcomes (1)

  • clinically and radiographically outcomes

    6, 12, 18, and 24 months

Secondary Outcomes (1)

  • histological outcome

    when the subjective tooth physically exfoliates from oral cavity

Study Arms (2)

GMTA

EXPERIMENTAL
Drug: Gray Mineral Trioxide Aggregate (GMTA)

20% FC

ACTIVE COMPARATOR
Drug: Diluted (20%) Formocresol (DFC)

Interventions

Once hemorrhage from the pulp chamber is under control using direct pressure of a sterile cotton pellet, pulp stumps are covered with a MTA paste, obtained by mixing 0.2g GMTA powder with sterile water in a powder to liquid ratio of 3:1 in weight. The GMTA will be then immediately covered with a zinc-oxide eugenol base (IRM) material.

Also known as: ProRoot MTA
GMTA

After the pulp hemostasis is achieved with direct pressure of a sterile cotton pellet, a sterile cotton pellet dampened with 20% DFC will be placed in contact with the pulp for 5 minutes, followed by the immediate placement of a zinc-oxide eugenol base (IRM) material.

Also known as: Buckley's Formo Cresol
20% FC

Eligibility Criteria

Age30 Months - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Primary first or second molars with normal pulp, reversible, or irreversible pulpitis, that have vital carious pulp exposures due to caries and whose pulp bled upon entering the pulp chamber.
  • Teeth in which hemostasis could be achieved with pressure of a saline dampened sterile cotton pellet prior to medicament/material placement.
  • No clinical symptoms or evidence of pulp degeneration, such as excessive bleeding from the root canal, history of swelling, mobility, or sinus tracts.
  • Patients with percussion sensitivity or spontaneous and persistent pain but where hemostasis could be achieved with pressure of sterile cotton pellet.
  • No radiographic signs of internal or external root resorption, inter-radicular and/or periapical bone destruction, or furcation radiolucency.
  • No more than one-third physiologic root resorption has occurred.
  • Teeth had not previously been pulpally treated.
  • Teeth deemed to be restorable with posterior stainless steel crowns.

You may not qualify if:

  • Not present

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Dentistry, National Taiwan University Hospital

Taipei, 10048, Taiwan

RECRUITING

MeSH Terms

Conditions

Dental CariesPulpitis

Interventions

ProRoot MTAformocresol

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic DiseasesDental Pulp Diseases

Study Officials

  • Yuan-Ling Lee, PhD

    Department of Dentistry, National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR
  • Hsiao-Hua Chang, MS

    Department of Dentistry, National Taiwan University Hospital

    STUDY CHAIR

Central Study Contacts

Yuan-Ling Lee, PhD

CONTACT

Hsiao-Hua Chang, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Dentistry

Study Record Dates

First Submitted

September 3, 2009

First Posted

September 7, 2009

Study Start

September 1, 2009

Primary Completion

July 1, 2013

Study Completion

July 1, 2014

Last Updated

August 23, 2012

Record last verified: 2012-08

Locations